A child receives a dose of the Pfizer-BioNTech vaccine against Covid-19 in Asuncion, Paraguay in July. Photo: AFP
A child receives a dose of the Pfizer-BioNTech vaccine against Covid-19 in Asuncion, Paraguay in July. Photo: AFP

Pfizer says its coronavirus vaccine safely bolsters antibodies in younger children

  • The results from a large-scale trial in kids ages five to 11 could pave the way for the inoculation of grade-school pupils
  • Pressure to immunise children is on the rise in the US as a new school year begins amid a Delta-fuelled Covid-19 surge

Topic |   Coronavirus pandemic
A child receives a dose of the Pfizer-BioNTech vaccine against Covid-19 in Asuncion, Paraguay in July. Photo: AFP
A child receives a dose of the Pfizer-BioNTech vaccine against Covid-19 in Asuncion, Paraguay in July. Photo: AFP
READ FULL ARTICLE